BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 26742637)

  • 61. Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra.
    Gervais J; Rouillard C
    Synapse; 2000 Mar; 35(4):281-91. PubMed ID: 10657038
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease.
    Laloux C; Petrault M; Lecointe C; Devos D; Bordet R
    Pharmacol Res; 2012 May; 65(5):514-22. PubMed ID: 22391246
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats.
    Barnum CJ; Chen X; Chung J; Chang J; Williams M; Grigoryan N; Tesi RJ; Tansey MG
    J Parkinsons Dis; 2014; 4(3):349-60. PubMed ID: 25061061
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-parkinsonian effects of Nurr1 activator in ubiquitin-proteasome system impairment induced animal model of Parkinson's disease.
    Zhang Z; Li X; Xie WJ; Tuo H; Hintermann S; Jankovic J; Le W
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):768-73. PubMed ID: 22483304
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A WNT1-regulated developmental gene cascade prevents dopaminergic neurodegeneration in adult En1(+/-) mice.
    Zhang J; Götz S; Vogt Weisenhorn DM; Simeone A; Wurst W; Prakash N
    Neurobiol Dis; 2015 Oct; 82():32-45. PubMed ID: 26049140
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.
    Anandhan A; Tamilselvam K; Radhiga T; Rao S; Essa MM; Manivasagam T
    Brain Res; 2012 Jan; 1433():104-13. PubMed ID: 22138428
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Daily consumption of methylene blue reduces attentional deficits and dopamine reduction in a 6-OHDA model of Parkinson's disease.
    Smith ES; Clark ME; Hardy GA; Kraan DJ; Biondo E; Gonzalez-Lima F; Cormack LK; Monfils M; Lee HJ
    Neuroscience; 2017 Sep; 359():8-16. PubMed ID: 28694175
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gremlin is a novel VTA derived neuroprotective factor for dopamine neurons.
    Phani S; Jablonski M; Pelta-Heller J; Cai J; Iacovitti L
    Brain Res; 2013 Mar; 1500():88-98. PubMed ID: 23348379
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Loss of dopaminergic neurons occurs in the ventral tegmental area and hypothalamus of rats following chronic stress: Possible pathogenetic loci for depression involved in Parkinson's disease.
    Sugama S; Kakinuma Y
    Neurosci Res; 2016 Oct; 111():48-55. PubMed ID: 27142317
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nigral and ventral tegmental area lesioning induces testicular and sperm morphological abnormalities in a rotenone model of Parkinson's disease.
    Awogbindin IO; Adedara IA; Adeniyi PA; Agedah AE; Oyetunde BF; Olorunkalu PD; Ogbuewu E; Akindoyeni IA; Mustapha YE; Ezekiel OG; Farombi EO
    Environ Toxicol Pharmacol; 2020 Aug; 78():103412. PubMed ID: 32439558
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Thiol Oxidation by Diamide Leads to Dopaminergic Degeneration and Parkinsonism Phenotype in Mice: A Model for Parkinson's Disease.
    Ray A; Kambali M; Ravindranath V
    Antioxid Redox Signal; 2016 Aug; 25(5):252-67. PubMed ID: 27121974
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators.
    Zhu W; Xie W; Pan T; Xu P; Fridkin M; Zheng H; Jankovic J; Youdim MB; Le W
    FASEB J; 2007 Dec; 21(14):3835-44. PubMed ID: 17690154
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Presence of proNGF-sortilin signaling complex in nigral dopamine neurons and its variation in relation to aging, lactacystin and 6-OHDA insults.
    Xia Y; Chen BY; Sun XL; Duan L; Gao GD; Wang JJ; Yung KK; Chen LW
    Int J Mol Sci; 2013 Jul; 14(7):14085-104. PubMed ID: 23880857
    [TBL] [Abstract][Full Text] [Related]  

  • 74. AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model.
    Ren X; Zhang T; Gong X; Hu G; Ding W; Wang X
    Exp Neurol; 2013 Oct; 248():148-56. PubMed ID: 23764500
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
    Rai SN; Yadav SK; Singh D; Singh SP
    J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anterior ventral tegmental area dopaminergic neurons are not involved in the motivational effects of bromocriptine, pramipexole and cocaine in drug-free rats.
    Ouachikh O; Dieb W; Durif F; Hafidi A
    Behav Brain Res; 2014 Apr; 262():1-7. PubMed ID: 24361908
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area.
    Prisco S; Esposito E
    Br J Pharmacol; 1995 Sep; 116(2):1923-31. PubMed ID: 8528581
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Role of Dopaminergic VTA Neurons in General Anesthesia.
    Zhou X; Wang Y; Zhang C; Wang M; Zhang M; Yu L; Yan M
    PLoS One; 2015; 10(9):e0138187. PubMed ID: 26398236
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: role of the intranigral graft.
    Baker KA; Sadi D; Hong M; Mendez I
    J Comp Neurol; 2000 Oct; 426(1):106-16. PubMed ID: 10980486
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
    Pienaar IS; Harrison IF; Elson JL; Bury A; Woll P; Simon AK; Dexter DT
    Brain Struct Funct; 2015 Jan; 220(1):479-500. PubMed ID: 24292256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.